Details

Autor(en) / Beteiligte

• Peláez-Ballestas, Ingris
• Sanin, Luz Helena
• Moreno-Montoya, José
• Alvarez-Nemegyei, José
• Burgos-Vargas, Rubén
• Garza-Elizondo, Mario
• Rodríguez-Amado, Jacqueline
• Goycochea-Robles, Maria-Victoria
• Madariaga, Marco
• Zamudio, Jorge
• Santana, Natalia
• Cardiel, Mario H

Titel

Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology

Ist Teil von

• Journal of rheumatology. Supplement, 2011-01, Vol.86, p.3-8

Ort / Verlag

Canada

Erscheinungsjahr

2011

Quelle

MEDLINE

Beschreibungen/Notizen

• To estimate the prevalence of musculoskeletal (MSK) disorders and to describe predicting variables associated with rheumatic diseases in 5 regions of México. This was a cross-sectional, community-based study performed in 5 regions in México. The methodology followed the guidelines proposed by the Community Oriented Program for the Control of the Rheumatic Diseases (COPCORD). A standardized methodology was used at all sites, with trained personnel following a common protocol of interviewing adult subjects in their household. A "positive case" was defined as an individual with nontraumatic MSK pain of > 1 on a visual analog pain scale (0 to 10) during the last 7 days. All positive cases were referred to internists or rheumatologists for further clinical evaluation, diagnosis, and proper treatment. The study included 19,213 individuals; 11,602 (68.8%) were female, and their mean age was 42.8 (SD 17.9) years. The prevalence of MSK pain was 25.5%, but significant variations (7.1% to 43.5%) across geographical regions occurred. The prevalence of osteoarthritis was 10.5%, back pain 5.8%, rheumatic regional pain syndromes 3.8%, rheumatoid arthritis 1.6%, fibromyalgia 0.7%, and gout 0.3%. The prevalence of MSK manifestations was associated with older age and female gender. The prevalence of MSK pain in our study was 25.5%. Geographic variations in the prevalence of MSK pain and specific diagnoses suggested a role for geographic factors in the prevalence of rheumatic diseases.